Bioforce AG, Switzerland acquired the remaining shares in joint venture Bioforce Denmark A/S, Denmark
Zurich – CFI Switzerland is pleased to announce that they supported Bioforce AG, Switzerland in the acquisition of the shares it did not already own in the joint venture with Bioforce Denmark A/S, Denmark. Prior to closing the transaction, Bioforce AG had a minority interest in Bioforce Denmark A/S.
Bioforce AG develops and produces phytopharmaceuticals, nutraceuticals and food supplements for international distribution. Besides its products, the philosophy of Bioforce is to focus on comprehensive and well-founded information on health topics. Bioforce has 350 employees and generates sales of approx. CHF 110 m.
Bioforce Denmark A/S is the exclusive distributor of Bioforce products in Denmark. The company is run by the founder and owner.
The parties agreed not to disclose further transaction details.
The transaction closed on 1 January 2019.
Healthcare & Life Sciences
acquired the shares it did not already own in its Danish distributor
Transaction details
Bioforce AG (Switzerland), which develops and produces phytopharmaceuticals, nutraceuticals and food supplements, acquired the shares it did not already own in the joint venture with Bioforce Denmark A/S (Denmark), which is the exclusive distributor of Bioforce products
This transaction was advised by:
Our latest transactions
Software & IT Services
have sold
to
a portfolio company of
Transaction details
Cevinio, a European software company specialising in AI-driven automation for Accounts Payable and Accounts Receivable processes, has been sold to Serrala, a global provider of finance process automation software, supporting end-to-end financial operations through a modular, cloud-ready platform
Real Estate & Construction
has sold its property in central Kuopio to
Transaction details
Finnish media group Keskisuomalainen Oyj has sold its property in central Kuopio to KPY Novapolis, providing adaptable office premises, and a wide range of business services
